16 January 2020 World Philippines’ Medicine Price Controls Will Boost Sales, Competition, Fitch Says Majority of the drugs affected by the Philippines’ maximum retail price scheme are new treatments for cancer, diabetes, and cardiovascular conditions.
14 January 2020 Malaysia Fitch: Drug Price Controls Will Benefit Malaysia’s Pharmaceutical Market Companies may benefit from a higher sales volume, offsetting some losses from lower medicine prices.
19 December 2019 Malaysia Affordable Medicine Access More Important Than Health Tourism, Fomca Says The median procurement price for originator drugs across the public and private sectors in Malaysia is about 8 times higher than international reference prices.
17 December 2019 Malaysia With Deregulated Fees, Don’t Oppose Medicine Price Controls, CAP Tells Health Providers Public display of medical practitioners’ consultation fees won’t necessarily empower patients either, says Consumers Association of Penang.
13 December 2019 Opinion Revisiting The Costs Of Medicine Price Controls Using cheaper but less effective drugs may lead to higher usage of other health care resources like hospitalisation.
11 December 2019 Malaysia Medical Inflation Justifies Drug Price Controls, MOH Says A study shows Malaysia has the third lowest medicine prices in the world.